Skip to main content
SpringerLink
Log in

Failure of Haemoperfusion to Reduce Flecainide Intoxication

A Case Study

  • Adverse Drug Experience Report
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Anderson JL, Stewart JR, Perry BA, van Hamersfeld DD, Johnson TA, et al. Oral flecainide acetate for the treatment of ventricular arrhythmias. New England Journal of Medicine 305: 473–477, 1981

    Article  PubMed  CAS  Google Scholar 

  • Becker JU. Determination of the plasma concentration of a new antiarrhythmic, flecainide, by high-performance liquid chromatography (HPLC): sample preparation using extraction columns. Journal of Clinical Chemistry and Clinical Biochemistry 22: 389–393, 1984

    CAS  Google Scholar 

  • Bexton RS, Hellestrand KJ, Nathan AW, Spanell RHJ, Camm AJ. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate. European Heart Journal 4: 92–102, 1983

    PubMed  CAS  Google Scholar 

  • Braun J, Kollert JR, Becker JU. Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function. European Journal of Clinical Pharmacology 31: 711–714, 1987

    Article  PubMed  CAS  Google Scholar 

  • Conard GJ, Cronheim GE, Klempt HW. Relationship between plasma concentrations and suppression of ventricular extra-systoles by flecainide acetate (R-818), a new antiarrhythmic, in patients. Arzneimittel-Forschung 32: 155–159, 1982

    PubMed  CAS  Google Scholar 

  • Conard GJ, Cronheim GE, Klempt HW, Ober RE. Human plasma pharmacokinetics of flecainide acetate (R-818), a new antiarrhythmic, following oral and intravenous doses. Clinical Pharmacology and Therapeutics 25: 218, 1979

    Google Scholar 

  • Conard GJ, Ober RE. Metabolism of flecainide. American Journal of Cardiology 53: 41b–51b, 1984

    Article  PubMed  CAS  Google Scholar 

  • Duff HJ, Roden DM, Maffucci RJ, Vesper BS, Conard GJ, et al. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. American Journal of Cardiology 48: 1113–1140, 1981

    Article  Google Scholar 

  • Fach WA, Mai BV, Preusler W, Becker HJ. Flecainide intoxication. Innere Medizin 11: 27–31, 1984

    Google Scholar 

  • Franciosa JA, Wilen M, Weeks CE, Tanebaum R, Kvam DC, et al. Pharmacokinetics and haemodynamic effects of flecainide in patients with chronic low output heart failure. Journal of the American College of Cardiology 1: 699, 1984

    Google Scholar 

  • Graben N. Entgiftung mit Hämoperfusion (Detoxification by haemoperfusion), pp. 201–216, Bindernagel, Friedberg/Hessen, 1980

    Google Scholar 

  • Hodges M, Haugland JM, Granrud G, Conard GJ, Asinger RW, et al. Suppression of ventricular ectopic depolarization by flecainide acetate, a new antiarrhythmic agent. Circulation 65: 879–885, 1982

    Article  PubMed  CAS  Google Scholar 

  • Johnston A, Carrington S, Turner P. Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH. British Journal of Clinical Pharmacology 20: 333–338, 1985

    Article  PubMed  CAS  Google Scholar 

  • Muhiddin KA, Johnston A, Turner P. The influence of urinary pH on flecainide excretion and its serum pharmacokinetics. British Journal of Clinical Pharmacology 17: 447–451, 1984

    Article  PubMed  CAS  Google Scholar 

  • Tjandramaga TB, Verbesselt R, van Hecken A, van Meile P, de Schepper PJ. Oral flecainide elimination kinetics: the effect of cimetidine. Circulation 68: 416, 1983

    Google Scholar 

  • Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. Journal of Clinical Pharmacology 24: 129–147, 1984

    PubMed  CAS  Google Scholar 

  • Wurzberger R, Wittner E, Avenhaus H, Hennemann H, Becker JU. Haemoperfusion in flecainide intoxication. Klinische Wochenschrift 64: 442–444, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Nephrology, University of Erlangen-Nuremburg, Kontuzmagarten 14-18, D-8500, Nuremberg 80, Germany

    J. Braun, J. R. Kollert, U. Gessler & J. U. Becker

  2. Kettelhack Riker Pharma GmbH, Borken, Germany

    J. Braun, J. R. Kollert, U. Gessler & J. U. Becker

Authors
  1. J. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Kollert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Gessler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. U. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braun, J., Kollert, J.R., Gessler, U. et al. Failure of Haemoperfusion to Reduce Flecainide Intoxication. Med Toxicol Adverse Drug Exp 2, 463–467 (1987). https://doi.org/10.1007/BF03259879

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259879

Keywords

Search

Navigation